We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microarrays Used for Blood Typing and Infectious Disease Diagnosis

By LabMedica International staff writers
Posted on 06 May 2009
Multiplex microarray assays are being developed to accelerate routine blood typing and the diagnosis of infectious diseases.

Scientists from the University of Edinburgh (Edinburgh, UK) are developing microarray technology and assays specifically to improve the understanding and diagnosis of infectious diseases, especially those caused by herpes viruses or human immunodeficiency virus (HIV). More...
They are using Tecan's (Männedorf, Switzerland) LS Reloaded laser scanner for automated scanning of both microplates and slides.

Dr. Colin Campbell, an investigator at the university, explained, "Our LS Reloaded scanner gives us the level of versatility that we need for assay development that other scanners could not provide. For example, the scanner allows a high degree of flexibility with a choice of materials and chip geometries so that we can scan from underneath or above, and can use silicon wafers and nonstandard chip sizes."

The Edinburgh scientists recently developed a microarray-based assay for ABO and Rhesus blood group typing, and are now developing this further to bring all the pretransfusion testing for other blood groups and infectious diseases together on one microarray. Dr. Campbell commented, "Our ultimate aim is to develop a single microarray-based test that will include all the critical antigens that must be matched for a successful blood transfusion to take place."

Tecan is a global supplier of laboratory instruments and solutions for the biopharma, forensic, and diagnostic industries. The company specializes in the development, production, and distribution of automation solutions for life science laboratories. Tecan's clients include pharmaceutic and biotech companies, university research departments, diagnostic laboratories and companies, as well as forensics laboratories. The company has production, research, and development sites in both North America and Europe and maintains a sales and service network in 52 countries.

Related Links:

University of Edinburgh
Tecan


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Clinical Chemistry Analyzer
Envoy 500+
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.